Healthcare - Sector
OCUL is currently covered by 10 analysts with an average price target of $26.19. This is a potential upside of $20.62 (370.2%) from yesterday's end of day stock price of $5.57.
Our record on OCUL covers 21 analysts since 2008; 10 cover it today. Of the 169 price targets those analysts set on OCUL, 93 were reached (55%). The highest performance score on OCUL belongs to Tara Bancroft of TD Cowen: 3.47, with 5 of 6 targets met in 110 days on average. The latest calls: Yi Chen of H.C. Wainwright kept the target at $28 with a Buy rating on 16 Nov 2026; Serge Belanger of Needham kept the target at $18 with a Buy rating on 18 Oct 2026; Andreas Argyrides of Chardan Capital kept the target at $23 with a Buy rating on 1 Oct 2026. Figures as of 18 Nov 2026.
Ocular Therapeutix's activity chart (see below) currently has 191 price targets and 179 ratings on display. The stock rating distribution of OCUL is 100% BUY.
Analysts' price targets on this stock were met 44.42% of the time, taking 361.34 days on average.
Highest price target for OCUL is $34, Lowest price target is $18, average price target is $26.19.
Most recent stock forecast was given by YI CHEN from HC WAINWRIGHT. First documented stock forecast 10-Mar-2015.
Currently out of the existing stock ratings of OCUL, 26 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 13-Oct-2021
$28
$22.43 (402.69%)
$28
4 days ago
(16-Nov-2026)
Buy Since 11-Mar-2025
$18
$12.43 (223.16%)
$18
1 months 2 days ago
(19-Oct-2026)
4/9 (44.44%)
$11.71 (186.17%)
214
Buy Since 25-Jun-2026
$23
$17.43 (312.93%)
$23
1 months 19 days ago
(02-Oct-2026)
0/4 (0%)
$16.04 (230.46%)
Buy Since 21-Apr-2023
$30
$20.16 (204.88%)
$24
5 months 3 days ago
(18-Jun-2026)
0/6 (0%)
$20.57 (218.13%)
Buy Since 09-Dec-2025
$30
$20.16 (204.88%)
$30
6 months 15 days ago
(06-May-2026)
0/2 (0%)
$20.29 (208.96%)
What is OCUL (Ocular Therapeutix) average time for price targets to be met?
Which analyst most recently updated their price target on OCUL (Ocular Therapeutix)?
Which analyst has the most public recommendations on OCUL (Ocular Therapeutix)?
Which analyst is the currently most bullish on OCUL (Ocular Therapeutix)?
Which analyst is the currently most reserved on OCUL (Ocular Therapeutix)?